Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19

27 Dec 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to Vaccine Coverage and Hesitancy
Share to Viral Infections and Outbreaks Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36575794
DOI: 10.1016/j.ymthe.2022.12.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19PMID 36575794Read ↗

First COVID-19 DNA vaccine approved, others in hot pursuitSemantic proximity Read ↗

DNA vaccines join the fight against COVID-19Semantic proximity Read ↗

Vaccine efficacy against COVID-19: A foresight on the host-associated factorsSemantic proximity Read ↗

COVID-19 vaccines: breaking record times to first-in-human trialsSemantic proximity Read ↗

Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trialSemantic proximity Read ↗

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious DiseasesSemantic proximity Read ↗

Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell ImmunitySemantic proximity Read ↗

Nature Of, Immune Reaction to and Side Effects of COVID-19 Vaccines: Synthesis of Information Including Exclusions from Ten Phase II Trials for Planning Vaccination ProgrammesSemantic proximity Read ↗

COVID-19 vaccinations: The unknowns, challenges, and hopes.Semantic proximity Read ↗

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesSemantic proximity Read ↗

Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate PlatformsSemantic proximity Read ↗

Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development ArenaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.